Prosight Management, LP Longboard Pharmaceuticals, Inc. Transaction History

Prosight Management, LP

  • $372 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$5.49 - $7.49 $2.27 Million - $3.1 Million
-413,743 Reduced 56.3%
321,154 $1.79 Million
Q2 2023

Aug 14, 2023
SELL
$4.19 - $10.05 $694,295 - $1.67 Million
-165,703 Reduced 18.4%
734,897 $5.39 Million
Q1 2023

May 12, 2023
BUY
$3.84 - $5.96 $3.46 Million - $5.37 Million
900,600 New
900,600 $3.61 Million

Others Institutions Holding LBPH

# of Institutions
126
Shares Held
34.9M
Call Options Held
28.9K
Put Options Held
13.9K
View Full List

About Longboard Pharmaceuticals, Inc.

LBPH Quotes by TradingView
  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $815M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email